Clinical Trial Update: VISmodegib for ORbital and Periocular Basal Cell Carcinoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for VISmodegib in orbital and periocular basal cell carcinoma completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Orbital Basal Cell Carcinoma
• Periocular Basal Cell Carcinoma

Drugs mentioned

• Vismodegib (Vismodegib)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Carcinoma, Basal Cell | Phase 4 | Status: COMPLETED | Results posted: 2021-10-28